Terzi, L. H. Et Al. 2021. Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12 .

Terzi, L. H., AKDOĞAN, N., DOĞAN GÜNAYDIN, S., & Atakan, N., (2021). Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12.

Terzi, Leyla Et Al. "Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre," INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12, 2021

Terzi, Leyla H. Et Al. "Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12, 2021

Terzi, L. H. Et Al. (2021) . "Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre." INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, no.12.

@article{article, author={Leyla Huseynova Terzi Et Al. }, title={Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre}, journal={INTERNATIONAL JOURNAL OF CLINICAL PRACTICE}, year=2021}